AVNS EBITDA Growth
Avanos Medical Inc · EBITDA Growth
AVNS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported93.65%period ending
AVNS TTM EBITDA YoY % (-47.63% → 93.65%)
Year-over-year change
High-resolution chart · PNG
AVNS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 93.6508% | |
| 94.3576% | |
| -618.4179% | |
| -678.6104% | |
| -642.5837% | |
| -749.6241% | |
| 40.6977% | |
| 2.2284% | |
| -25.179% | |
| -45.1546% | |
| -40.2778% | |
| -19.7765% | |
| 20.0573% | |
| 104.6414% | |
| 580% | |
| 479.2373% | |
| 520.4819% | |
| 2,470% | |
| -151.2195% | |
| -206.7873% | |
| -222.0588% | |
| 83.4711% | |
| 326.5193% | |
| 172.8395% | |
| -48.0916% | |
| -128.9474% | |
| -138.0252% | |
| -72.8188% | |
| 172.9167% | |
| -17.5542% | |
| -36.1074% | |
| -73.3691% | |
| -93.7296% | |
| -68.0931% | |
| -52.8481% | |
| 132.8249% | |
| 144.6746% | |
| 147.5606% | |
| 148.7504% | |
| -326.964% | |
| -371.7684% | |
| -315.8269% | |
| -273.1303% | |
| -42.4962% | |
| -60.8263% | |
| -47.6319% |